MAR vs NVDA: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and NVIDIA Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-20.
Marriott International, Inc. Β· Consumer Cyclical
$366.24
-3.4% upside to fair value
Med Conviction Grade C
VS
NVIDIA Corporation Β· Technology
$210.69
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NVDA has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR NVDA
Current Price $366.24 $210.69
Fair Value Estimate $353.64 $305.50
Upside to Fair Value -3.4% +45.0%
Market Cap $96.6B $5,103.1B
Forward P/E β€” 32.1x
EV / EBITDA 23.8x 26.5x
Price / Sales 3.7x 20.1x
Price / FCF 31.6x 42.9x
Revenue Growth YoY +6.2% +85.2%
Gross Margin 21.4% 74.1%
Operating Margin 16.0% 64.0%
Return on Equity -74.1% 111.7%
Dividend Yield 0.75% 0%
FCF Yield 3.17% 2.33%
Analyst Consensus Hold Strong Buy
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor, manager and licensor whose high-quality brands, nearly 283 million Bonvoy members, more than 9,900 properties across 146 countries and record 4,107-property development pipeline create meaningful network, distribution and brand advantages. Q1 2026 demonstrated resilient underlying fee economics: adjusted revenue excluding cost-reimb…
NVDA β€” NVIDIA Corporation
NVIDIA Corporation is a leading technology company specializing in semiconductors, particularly GPUs and AI accelerators, with a dominant market position in AI training markets holding over 80% share. The company exhibits exceptional business quality with a founder-led management team boasting over 30 years of continuous leadership, very high profitability with gross margins above 74% and net mar…
Accumulation Zones
Metric MAR NVDA
Zone Low $265.23 $229.12
Zone High $300.59 $259.68
In Buy Zone? No Yes
← MAR Research    NVDA Research β†’    All Research